• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制 NF-κB 可提高对放疗和 EGFR-TKIs 的敏感性,并降低放疗引起的肺毒性。

Inhibition of NF-κB improves sensitivity to irradiation and EGFR-TKIs and decreases irradiation-induced lung toxicity.

机构信息

Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, Guangdong Province, People's Republic of China.

出版信息

Int J Cancer. 2019 Jan 1;144(1):200-209. doi: 10.1002/ijc.31907. Epub 2018 Oct 31.

DOI:10.1002/ijc.31907
PMID:30289964
Abstract

Resistance to radiotherapy and to EGFR tyrosine kinase inhibitors (EGFR-TKIs), as well as therapy-related lung toxicity, are serious problems in the treatment of lung cancer. NF-κB has been reported to be associated with radioresistance. Therefore, we evaluated its effects on sensitivity to irradiation and to EGFR-TKIs; irradiation-induced lung toxicity; and the effects of irradiation on sensitivity to EGFR-TKIs. We used IKKβ inhibitor IMD 0354 or p65 depletion to explore their effects on sensitivity to irradiation and to EGFR-TKIs in vitro and in vivo. We evaluated the efficacy of IMD 0354 in a radiation-induced pulmonary-fibrosis mouse model. Irradiation enhanced activation and expression of MET and therefore suppressed the sensitivity of lung cancer cells to irradiation or EGFR-TKIs. Inhibition of NF-κB by IMD 0354 or by p65 depletion reversed irradiation-induced MET activation and increased the sensitivity of lung cancer cells to irradiation, to EGFR-TKIs and to the combination thereof in vitro and in vivo. In addition, IMD 0354 significantly reduced lung toxicity in a murine model of irradiation-induced pneumonia and lung fibrosis. These findings indicated that NF-κB inhibition can improve sensitivity to irradiation and to EGFR-TKIs and can decrease irradiation-induced lung toxicity in lung cancer.

摘要

放疗抵抗和表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKIs)耐药以及与治疗相关的肺毒性是肺癌治疗中的严重问题。已有报道称 NF-κB 与放射抵抗有关。因此,我们评估了其对辐射和 EGFR-TKIs 敏感性、辐射诱导的肺毒性以及辐射对 EGFR-TKIs 敏感性的影响。我们使用 IKKβ 抑制剂 IMD 0354 或 p65 耗竭来探讨其在体外和体内对辐射和 EGFR-TKIs 敏感性的影响。我们在辐射诱导的肺纤维化小鼠模型中评估了 IMD 0354 的疗效。辐射增强了 MET 的激活和表达,从而抑制了肺癌细胞对辐射或 EGFR-TKIs 的敏感性。通过 IMD 0354 或 p65 耗竭抑制 NF-κB 可逆转辐射诱导的 MET 激活,增加肺癌细胞对辐射、EGFR-TKIs 及其联合应用的敏感性,无论是在体外还是在体内。此外,IMD 0354 可显著降低辐射诱导肺炎和肺纤维化小鼠模型中的肺毒性。这些发现表明,NF-κB 抑制可提高辐射和 EGFR-TKIs 的敏感性,并降低肺癌中辐射诱导的肺毒性。

相似文献

1
Inhibition of NF-κB improves sensitivity to irradiation and EGFR-TKIs and decreases irradiation-induced lung toxicity.抑制 NF-κB 可提高对放疗和 EGFR-TKIs 的敏感性,并降低放疗引起的肺毒性。
Int J Cancer. 2019 Jan 1;144(1):200-209. doi: 10.1002/ijc.31907. Epub 2018 Oct 31.
2
Inhibition of lung tumor growth by targeting EGFR/VEGFR-Akt/NF-κB pathways with novel theanine derivatives.通过新型茶氨酸衍生物靶向表皮生长因子受体/血管内皮生长因子受体-蛋白激酶B/核因子-κB信号通路抑制肺癌肿瘤生长
Oncotarget. 2014 Sep 30;5(18):8528-43. doi: 10.18632/oncotarget.2336.
3
Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines.金雀异黄素增强表皮生长因子受体酪氨酸激酶抑制剂的作用并抑制非小细胞肺癌细胞系中的核因子κB。
Cancer. 2009 May 15;115(10):2165-76. doi: 10.1002/cncr.24250.
4
NF-κB signaling is activated and confers resistance to apoptosis in three-dimensionally cultured EGFR-mutant lung adenocarcinoma cells.NF-κB 信号通路被激活,并赋予三维培养的 EGFR 突变型肺腺癌细胞抗细胞凋亡的能力。
Biochem Biophys Res Commun. 2012 Jul 13;423(4):667-71. doi: 10.1016/j.bbrc.2012.06.009. Epub 2012 Jun 10.
5
NF-κB activation is an early event of changes in gene regulation for acquiring drug resistance in human adenocarcinoma PC-9 cells.NF-κB 的激活是人类腺癌细胞 PC-9 获得药物耐药性时基因调控变化的早期事件。
PLoS One. 2018 Aug 3;13(8):e0201796. doi: 10.1371/journal.pone.0201796. eCollection 2018.
6
A new IkappaB kinase beta inhibitor prevents human breast cancer progression through negative regulation of cell cycle transition.一种新型IκB激酶β抑制剂通过对细胞周期转换的负调控来阻止人类乳腺癌进展。
Cancer Res. 2006 Jan 1;66(1):419-26. doi: 10.1158/0008-5472.CAN-05-0741.
7
The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.长链非编码RNA GAS5通过下调IGF-1R表达,增强吉非替尼对具有野生型EGFR的原发性EGFR酪氨酸激酶抑制剂耐药肺腺癌细胞的诱导细胞死亡作用。
J Hematol Oncol. 2015 Apr 29;8:43. doi: 10.1186/s13045-015-0140-6.
8
The Novel IκB Kinase β Inhibitor, IMD-0560, Has Potent Therapeutic Efficacy in Ovarian Cancer Xenograft Model Mice.新型IκB激酶β抑制剂IMD-0560在卵巢癌异种移植模型小鼠中具有强大的治疗效果。
Int J Gynecol Cancer. 2016 May;26(4):610-8. doi: 10.1097/IGC.0000000000000668.
9
Downregulation of caveolin-1 increased EGFR-TKIs sensitivity in lung adenocarcinoma cell line with EGFR mutation.小窝蛋白-1的下调增加了具有表皮生长因子受体(EGFR)突变的肺腺癌细胞系对EGFR酪氨酸激酶抑制剂(EGFR-TKIs)的敏感性。
Biochem Biophys Res Commun. 2018 Jan 1;495(1):733-739. doi: 10.1016/j.bbrc.2017.11.075. Epub 2017 Nov 12.
10
Dual MET and SMO Negative Modulators Overcome Resistance to EGFR Inhibitors in Human Nonsmall Cell Lung Cancer.双 MET 和 SMO 负性调节剂克服人非小细胞肺癌对 EGFR 抑制剂的耐药性。
J Med Chem. 2017 Sep 14;60(17):7447-7458. doi: 10.1021/acs.jmedchem.7b00794. Epub 2017 Aug 22.

引用本文的文献

1
Stimuli-Responsive Peptide/siRNA Nanoparticles as a Radiation Sensitizer for Glioblastoma Treatment by Co-Inhibiting RELA/P65 and EGFR.基于共抑制 RELA/P65 和 EGFR 的刺激响应型肽/siRNA 纳米颗粒作为脑胶质母细胞瘤治疗的增敏剂。
Int J Nanomedicine. 2024 Nov 9;19:11517-11537. doi: 10.2147/IJN.S483252. eCollection 2024.
2
FACT inhibitor CBL0137, administered in an optimized schedule, potentiates radiation therapy for glioblastoma by suppressing DNA damage repair.FACT抑制剂CBL0137按照优化方案给药,通过抑制DNA损伤修复增强胶质母细胞瘤的放射治疗效果。
Res Sq. 2024 Sep 9:rs.3.rs-4830689. doi: 10.21203/rs.3.rs-4830689/v1.
3
FACT inhibitor CBL0137, administered in an optimized schedule, potentiates radiation therapy for glioblastoma by suppressing DNA damage repair.
FACT抑制剂CBL0137按照优化方案给药,通过抑制DNA损伤修复增强胶质母细胞瘤的放射治疗效果。
J Neurooncol. 2024 Dec;170(3):621-630. doi: 10.1007/s11060-024-04819-8. Epub 2024 Sep 9.
4
Review: Mechanisms and perspective treatment of radioresistance in non-small cell lung cancer.综述:非小细胞肺癌放射抵抗的机制和治疗视角。
Front Immunol. 2023 Feb 14;14:1133899. doi: 10.3389/fimmu.2023.1133899. eCollection 2023.
5
Lung Pneumonitis and Fibrosis in Cancer Therapy: A Review on Cellular and Molecular Mechanisms.癌症治疗中的肺部肺炎与纤维化:细胞和分子机制综述
Curr Drug Targets. 2022;23(16):1505-1525. doi: 10.2174/1389450123666220907144131.
6
Insight of a Metabolic Prognostic Model to Identify Tumor Environment and Drug Vulnerability for Lung Adenocarcinoma.代谢预后模型洞察肺腺癌的肿瘤微环境和药物易损性。
Front Immunol. 2022 Jun 23;13:872910. doi: 10.3389/fimmu.2022.872910. eCollection 2022.
7
Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism.基于可操作的 S100A9/RAGE 耐药机制对脑转移瘤的放射敏感性进行分层。
Nat Med. 2022 Apr;28(4):752-765. doi: 10.1038/s41591-022-01749-8. Epub 2022 Apr 11.
8
Prognostic values, ceRNA network, and immune regulation function of SDPR in KRAS-mutant lung cancer.SDPR在KRAS突变型肺癌中的预后价值、ceRNA网络及免疫调节功能
Cancer Cell Int. 2021 Jan 12;21(1):49. doi: 10.1186/s12935-021-01756-8.
9
Silencing of lncRNA LINC00857 Enhances BIRC5-Dependent Radio-Sensitivity of Lung Adenocarcinoma Cells by Recruiting NF-κB1.lncRNA LINC00857的沉默通过招募NF-κB1增强肺腺癌细胞中BIRC5依赖的放射敏感性。
Mol Ther Nucleic Acids. 2020 Sep 23;22:981-993. doi: 10.1016/j.omtn.2020.09.020. eCollection 2020 Dec 4.
10
Association between NF-B Activation in Peripheral Blood Mononuclear Cells and Late Skin and Subcutaneous Fibrosis following Radiotherapy.外周血单个核细胞中 NF-B 激活与放疗后晚期皮肤和皮下组织纤维化的关系。
Biomed Res Int. 2020 Jul 21;2020:2957818. doi: 10.1155/2020/2957818. eCollection 2020.